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化学修饰连接靶向 ASGPR 的糖分子，验证其作为新型酶替代疗法的潜在可行性。 
我们通过定点突变 (site-directed mutagenesis) 把精氨酸酶上选定的氨基酸 













































Arginase catalyzes the hydrolysis of L-arginine into L-ornithine and urea as the 
final step of urea cycle in liver. Arginemia stems from genetic disorders which result 
in decreasing of arginase activity and elevated concentration of arginine and ammonia 
in blood. The abnormal high concentrations of arginine and `ammonia can eventually 
lead to death of patients. To date, there is no effective therapy towards arginemia.   
Asialo-glycoprotein receptor, abundantly expressed on the cell surface in liver, 
binds galactose/N-acetylgalactose terminated glycoproteins. Subsequently the surface 
bound glycoproteins are taken up into cells by endocytosis. Based on the well 
established properties of ASGPR, we envision that catalytically active arginase 
modified with chemical probes containing terminal galactose might be recognized and 
delivered into liver via the interaction of ASGPR, which might be a potential enzyme 
replacement therapy against arginemia. 
Experimentally, selected amino acids of arginase were mutated into cysteine.  
Site-directed chemical modification of the introduced thiol group of arginase mutants 
(Asn60Cys, Arg222Cys, Ser2,3Cys) with lactose derivatives afforded glycosylated 
arginase mutants with various number (3 or 6) of terminal galactose for multivalent 
binding with cell surface receptors. Arginase mutant (Ser2,3Cys) was also conjugated 
to mannose displaying nanoparticles for delivery into macrophages via cell surface 
mannose receptor. 
The chemically modified mutants were incubated with selected liver cells or 
macrophage cells. The interactions were characterized with Flow Cytometry, 
Fluorescence Confocal Microscopy and arginase activity determination. The results 
showed that chemically glycosylated arginase mutants were efficiently taken up in 
cells at lower concentrations relative to unmodified enzyme. Delivery of arginase into 
macrophage was also shown to inhibit the production of nitric oxide due to depletion 
of arginine, the common substrate of arginase and nitric oxide synthetase. 















or mannosylated arginase can be efficiently incorporated into selected cells depends 
on the nature of the glycoprobes, suggesting the utility of chemically modified 
arginase in the development of new enzyme replacement therapy of arginemia.  
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